Medicinal Genomics Launches PathogINDICAtor, A Novel And Automated Microbial Screening Kit For Cannabis
WOBURN, Mass.--(BUSINESS WIRE)--Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of PathogINDICAtor™, a highly robust and automated microbial screening assay for Cannabis.
The PathogINDICAtor™ assay is a novel test designed to accurately detect microbial contamination in medical Cannabis plant material. Toxic mold and bacteria are not desirable in any consumed product, but it is of particular concern with medical Cannabis products, due to the acute risk posed to seriously ill patients who already may have weakened immune systems.
Help employers find you! Check out all the jobs and post your resume.
The PathogINDICAtor™ assay is a novel test designed to accurately detect microbial contamination in medical Cannabis plant material. Toxic mold and bacteria are not desirable in any consumed product, but it is of particular concern with medical Cannabis products, due to the acute risk posed to seriously ill patients who already may have weakened immune systems.
Help employers find you! Check out all the jobs and post your resume.